The company specializes in clearing senescent cells using senolytic medicines that target unique vulnerabilities in these cells, leaving normal cells unaffected. Unity Biotechnology focuses on age-related diseases such as osteoarthritis, eye diseases, and pulmonary diseases, and aims to slow, halt or reverse these diseases by selectively eliminating or modulating senescent cells. More information is available on their website.